A.R.T. Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,647
Closed -$556K 1925
2019
Q3
$556K Buy
+13,647
New +$589K 0.03% 816
2019
Q1
Sell
-25,984
Closed -$1.55M 1809
2018
Q4
$1.55M Buy
25,984
+15,700
+153% +$943K 0.1% 298
2018
Q3
$662K Sell
10,284
-500
-5% -$27.9K 0.03% 736
2018
Q2
$485K Buy
+10,784
New +$430K 0.02% 935
2018
Q1
Sell
-7,584
Closed -$226K 1942
2017
Q4
$226K Sell
7,584
-4,300
-36% -$125K 0.01% 1122
2017
Q3
$392K Buy
+11,884
New +$412K 0.02% 910
2017
Q1
Sell
-22,400
Closed -$500K 1931
2016
Q4
$500K Buy
+22,400
New +$438K 0.03% 751
2016
Q3
Sell
-25,535
Closed -$416K 1539
2016
Q2
$416K Buy
25,535
+4,100
+19% +$60.3K 0.02% 863
2016
Q1
$250K Buy
+21,435
New +$240K 0.01% 1101
2015
Q3
Sell
-48,553
Closed -$457K 1849
2015
Q2
$457K Buy
+48,553
New +$449K 0.02% 1022
2015
Q1
Sell
-44,404
Closed -$445K 1944
2014
Q4
$445K Buy
+44,404
New +$381K 0.02% 967
2014
Q1
Sell
-50,848
Closed -$403K 1785
2013
Q4
$403K Sell
50,848
-28,110
-36% -$262K 0.02% 863
2013
Q3
$782K Buy
78,958
+53,448
+210% +$421K 0.04% 604
2013
Q2
$150K Buy
+25,510
New +$85.8K ﹤0.01% 1199

Other funds holding BEAT

A.R.T. Advisors's BEAT Position: Q4 2019 in Review

A.R.T. Advisors sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 13,647 shares — an estimated $556K sold.

A.R.T. Advisors first reported a position in BEAT in Q2 2013 and held it in 14 quarters. The position peaked at $1.55M in Q4 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • A.R.T. Advisors reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 13,647 BioTelemetry, Inc. shares in Q4 2019, an estimated $556K.
  • A.R.T. Advisors first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 14 quarters.
  • A.R.T. Advisors's BioTelemetry, Inc. position peaked at $1.55M in Q4 2018.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.